Project: Development of a self-testing device to measure Phenylalanine levels for Phenylketonuria monitoring

Acronym EGOPhe (Reference Number: 12922)
Duration 01/03/2019 - 02/03/2021
Project Topic EGOPhe aims at seizing a 70+M€/year business opportunity in patient self-monitoring, by developing a new fluorometric lab assay to quantify Phenylalanine (Phe) levels in the blood and integrate it in a already developed handheld medical device - the EGO3 System, already demonstrated for other applications. By validating this new assay for the EGO3 System we will offer to 100 000+ patients worldwide the first home test, for instant, lab-grade monitoring of Phenylketonuria (PKU) disorder.
Network Eurostars 2
Call Eurostars Cut–off 10

Project partner

Number Name Role Country
1 Percuros B.V. Coordinator Netherlands
2 Leiden University Medical Centre Partner Netherlands
3 ChipDx ApS Partner Denmark